Genmab | Nettoindtægt



Net Income Lave om Dato
Agios Pharmaceuticals USD -96523000 1.04B 2024-12
Almirall EUR 7.99M 590K 2024-06
Amarin USD -25134000 26.66M 2024-09
Amgen USD 627M 2.2B 2024-12
argenx SE USD 774.16M 682.75M 2024-12
AstraZeneca USD 1.5B 71M 2024-12
Bayer EUR -335000000 3.85B 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Demant DKK 1.19B 588.5M 2024-12
Exelixis USD 139.86M 21.89M 2025-01
Fresenius Medical Care EUR 66.9M 146.1M 2024-12
Galapagos EUR 25.31M 75.74M 2024-12
Genmab DKK 3.84B 2.58B 2024-12
GlaxoSmithKline GBP 414M 472M 2024-12
GN Store Nord DKK 367M 96M 2024-12
GRIFOLS EUR 68.97M 17.28M 2024-12
Hikma Pharmaceutical USD 226M 167M 2024-06
Insmed USD -235548000 15.02M 2024-12
Lonza CHF 329M 85M 2024-06
Merck EUR 809M 202M 2024-09
Novartis USD 2.82B 371M 2024-12
Regeneron Pharmaceuticals USD 917.7M 422.9M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 2.82B 1.7B 2024-09
UCB EUR 104M 72M 2024-06



Genmab Nettoindtægt - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.